nicardipine has been researched along with bromodeoxyuridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futamura, Y; Hamada, Y | 1 |
| Katayama, T; Kuroda, H; Kyan, H; Murakami, N; Nakashima, M; Rahayu, EY | 1 |
2 other study(ies) available for nicardipine and bromodeoxyuridine
| Article | Year |
|---|---|
Induction of Leydig cell tumors by lacidipine via up-regulation of the LHRH receptor on Leydig cells in rats.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Leydig Cell Tumor; Leydig Cells; Luteinizing Hormone; Macaca mulatta; Male; Mice; Nicardipine; Protein Kinases; Proto-Oncogenes; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Species Specificity; Testosterone; Up-Regulation | 1998 |
Involvement of distinct signaling pathways in activin-induced increases in FSH secretion and enlargement of FSH cell population in the rat pituitary.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Activins; Animals; Antibody Specificity; Bromodeoxyuridine; Calcium Channel Blockers; Calcium Channels; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Growth Substances; Humans; Inhibins; Nicardipine; Pituitary Gland, Anterior; Rats; Signal Transduction | 2000 |